Metacrine

$4.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-5.95%) Today
-$0.09 (-1.84%) As of 9:21 AM UTC after-hours

Why Robinhood?

You can buy or sell Metacrine and other stocks, options, and ETFs commission-free!

About MTCR

Metacrine, Inc. Common Stock, also called Metacrine, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases.

CEO
Preston S. Klassen
Employees
35
Headquarters
San Diego, California
Founded
2014
Market Cap
135.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
157.91K
High Today
$5.20
Low Today
$4.80
Open Price
$5.20
Volume
183.64K
52 Week High
$16.19
52 Week Low
$4.80

MTCR Earnings

-$1.41
-$0.94
-$0.47
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

OEF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure